Topics:

Gynecological Oncology

Cervical Cancer: Is a New Detection Method Coming?

A simple blood test using plasma thermogram could serve as an effective new indicator for detecting cervical cancer, including assessment of the cancer’s stage.

Gynecological Oncology

The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.

Eradicating morcellators is riskier than using them, says the AAGL in a statement for why these minimally invasive devices should not be abandoned.

A large insurance company has decided to no longer cover laparoscopic power morcellation. Is this the beginning of the end of power morcellators?

The best-ranked hospitals for gynecology have once again been listed by U.S. News & World Report. We noticed a trend—observational only—and want to know what you think.

Researchers found that uterine cancers were present in 27 per 10,000 women undergoing morcellation, which fragments the uterus and can spread cancer cells.

The optimal time to get the HPV vaccine is before a first sexual encounter. But getting the vaccine after still offers significant protection against cervical dysplasia.

The morcellation controversy heats up as physicians all over the world who use Ethicon power morcellators are being asked to return the medical devices.

Pages

Subscribe to Gynecological Oncology on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.